Ensign Peak Advisors
ASPN icon

Ensign Peak Advisors’s Aspen Aerogels ASPN Stock Holding History

Ensign Peak Advisors’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,760
Closed -$35K – 1815
2022
Q3 		$35K Buy
+3,760
New +$45.5K ﹤0.01% 2262

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Ensign Peak Advisors's ASPN Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Aspen Aerogels (ASPN) in Q4 2022, closing a stake of 3,760 shares — an estimated $35K sold.

Ensign Peak Advisors first reported a position in ASPN in Q3 2022 and held it in 1 quarter. The position peaked at $35K in Q3 2022. 164 funds tracked by Wall St. Rank hold ASPN as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Aspen Aerogels position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 3,760 Aspen Aerogels shares in Q4 2022, an estimated $35K.
  • Ensign Peak Advisors first reported a position in Aspen Aerogels in Q3 2022 and held it in 1 quarter.
  • Ensign Peak Advisors's Aspen Aerogels position peaked at $35K in Q3 2022.
  • 164 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.